Vascular SurgeryRenal
AV Fistula / Dialysis Access
Pre-emptive AVF creation; recognise complications (thrombosis, infection, steal, aneurysm); urgent referral.
Source: Renal Association; UK Vascular Society
Step 1 of ~3
info
Pre-emptive Creation + Maturation
Best access for haemodialysis: native arteriovenous fistula (AVF) — long patency, low infection.
Alternatives: AV graft (prosthetic — quicker maturation, higher infection / thrombosis), tunnelled central venous catheter (last resort, risk infection).
Pre-emptive AVF creation:
• Refer patients with eGFR <20 to vascular surgery for AVF creation 3–6 months before anticipated dialysis (allows maturation).
• Vein mapping + arterial Doppler pre-op.
• Common sites: radiocephalic (preferred), brachiocephalic, brachiobasilic transposition.
• Maturation: ~6 weeks; assess by physical exam (thrill, bruit), USS (flow >600 mL/min, vein diameter ≥6 mm).
• Pre-fistula vein protection: avoid IV cannulation in vein to be used.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Flucloxacillin (Burns — Wound Infection) · Antibiotic — Penicillinase-Resistant Penicillin
- Colistin (Polymyxin E — XDR Burns Infection) · Antibiotic — Polymyxin (Last-Resort)
- Deferoxamine (Iron/Aluminium Overload in Dialysis) · Iron/Aluminium Overload in Dialysis
- Octreotide (Surgical — Fistula/Carcinoid) · Somatostatin Analogue
- Dalteparin · Low Molecular Weight Heparin — VTE Treatment / Cancer-Associated Thrombosis
Pathways
Decision support only. Always apply local guidelines and clinical judgement.